Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
21.32
Dollar change
+0.02
Percentage change
0.09
%
Index- P/E- EPS (ttm)-1.47 Insider Own38.59% Shs Outstand79.70M Perf Week0.57%
Market Cap1.81B Forward P/E- EPS next Y-1.66 Insider Trans0.00% Shs Float52.01M Perf Month74.75%
Income-94.90M PEG- EPS next Q-0.37 Inst Own49.90% Short Float15.23% Perf Quarter134.80%
Sales2.07M P/S872.27 EPS this Y0.99% Inst Trans-2.66% Short Ratio3.57 Perf Half Y777.37%
Book/sh2.79 P/B7.64 EPS next Y-15.48% ROA-37.59% Short Interest7.92M Perf Year458.12%
Cash/sh2.76 P/C7.71 EPS next 5Y- ROE-49.34% 52W Range2.31 - 21.44 Perf YTD121.85%
Dividend Est.- P/FCF- EPS past 5Y-80.83% ROI-35.32% 52W High-0.56% Beta-0.73
Dividend TTM- Quick Ratio15.01 Sales past 5Y8.60% Gross Margin- 52W Low822.94% ATR (14)0.98
Dividend Ex-Date- Current Ratio15.01 EPS Y/Y TTM26.68% Oper. Margin-4798.45% RSI (14)83.42 Volatility0.70% 5.32%
Employees113 Debt/Eq0.23 Sales Y/Y TTM41.55% Profit Margin-4588.83% Recom2.85 Target Price21.23
Option/ShortYes / Yes LT Debt/Eq0.21 EPS Q/Q29.90% Payout- Rel Volume0.70 Prev Close21.30
Sales Surprise-100.00% EPS Surprise-15.04% Sales Q/Q-100.00% EarningsMar 20 AMC Avg Volume2.22M Price21.32
SMA2051.17% SMA5071.92% SMA200233.17% Trades Volume1,564,293 Change0.09%
Date Action Analyst Rating Change Price Target Change
Dec-27-23Upgrade Raymond James Outperform → Strong Buy $12 → $15
Sep-29-23Initiated Oppenheimer Outperform $13
Jun-23-23Initiated Raymond James Outperform $13
Dec-01-22Resumed B. Riley Securities Buy $10
Nov-30-22Initiated SVB Leerink Outperform $6
Sep-16-22Initiated Truist Buy $10
Jul-06-22Initiated William Blair Outperform
Oct-19-21Resumed Morgan Stanley Overweight $19
Aug-26-21Initiated B. Riley Securities Buy $17
Jul-21-20Initiated Wedbush Outperform $25
Mar-25-24 02:52PM
Mar-20-24 09:53PM
05:51PM
04:05PM
01:21PM
04:28PM Loading…
Mar-19-24 04:28PM
04:02PM
02:34PM
01:24PM
12:42PM
12:40PM
11:15AM
11:13AM
10:46AM
10:39AM
09:03AM Loading…
09:03AM
08:59AM
07:56AM
07:38AM
04:01AM
03:22AM
03:10AM
03:07AM
03:00AM
Mar-06-24 07:45AM
Mar-05-24 04:43PM
Feb-26-24 10:50AM
07:45AM
Feb-20-24 06:30AM
Feb-19-24 01:31PM
08:45AM Loading…
Feb-16-24 08:45AM
Feb-07-24 07:45AM
Feb-06-24 04:45PM
Jan-25-24 09:55AM
Jan-17-24 12:00PM
Jan-16-24 12:00PM
08:22AM
Jan-10-24 08:34AM
Jan-09-24 06:21PM
Jan-04-24 04:05PM
Dec-28-23 01:11PM
Dec-27-23 02:42PM
11:02AM
Dec-13-23 09:55AM
Dec-08-23 12:00PM
Nov-27-23 09:55AM
Nov-16-23 06:45AM
06:45AM
Nov-08-23 04:15PM
08:15AM
Nov-07-23 08:28AM
08:25AM
07:00AM
Oct-16-23 07:50AM
Oct-12-23 07:45AM
Sep-06-23 04:25PM
Sep-05-23 04:10PM
Aug-14-23 07:55AM
Aug-09-23 04:05PM
Aug-08-23 08:15AM
07:00AM
Aug-05-23 03:30PM
Jul-06-23 04:05PM
Jun-29-23 10:08AM
Jun-26-23 08:05AM
Jun-16-23 08:05AM
Jun-07-23 07:35AM
May-31-23 04:10PM
10:58AM
May-12-23 06:09AM
May-11-23 07:15AM
May-10-23 08:34AM
May-09-23 07:45AM
May-02-23 04:00PM
Apr-20-23 04:15PM
Apr-19-23 04:25PM
Apr-13-23 09:47AM
Apr-12-23 04:05PM
Apr-05-23 04:10PM
Mar-20-23 04:05PM
Mar-16-23 08:45AM
07:30AM
Mar-08-23 04:35PM
Mar-02-23 04:35PM
Feb-14-23 07:59AM
Feb-13-23 04:05PM
08:05AM
Feb-07-23 04:10PM
Jan-20-23 08:33AM
Jan-06-23 07:45AM
Jan-05-23 05:00PM
Jan-04-23 04:35PM
Dec-22-22 09:52AM
Dec-07-22 04:15PM
Nov-09-22 07:10AM
Nov-08-22 08:25AM
07:00AM
Nov-07-22 04:25PM
Oct-28-22 07:11AM
Oct-13-22 12:00PM
Fusion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It develops GMP manufacturing of radiopharmaceuticals for the diagnosis and treatment of disease. The company was founded by John Vaillant in 2014 and is headquartered in Hamilton, Canada.